Purkinje Cells are specialized neurons located in the cerebellum, a region of the brain involved in motor coordination and control. Named after the Czech anatomist Jan Evangelista Purkyn?, these cells boast an elaborate and distinctive dendritic arborization. With a single large dendritic tree extending horizontally, Purkinje cells receive inputs from parallel fibers carrying information about motor commands and sensory feedback. Axons of Purkinje cells serve as the sole output from the cerebellar cortex, projecting inhibitory signals to the deep cerebellar nuclei. The complex branching pattern of Purkinje cells allows them to integrate and modulate signals, playing a pivotal role in fine-tuning motor movements. Dysfunction of Purkinje cells is implicated in various neurological disorders, such as ataxia, where impaired coordination and balance are prevalent. Furthermore, these cells are particularly susceptible to conditions like cerebellar degeneration. Research on Purkinje cells provides valuable insights into the neural mechanisms underpinning motor control and serves as a foundation for understanding cerebellar function in health and disease. Advances in neurobiology continue to uncover the intricate roles played by Purkinje cells, contributing to our understanding of cerebellar circuitry and potential therapeutic strategies for related disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States